Related Experiment Video

Updated: Aug 15, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas

Tracey J Mitchell1, Susan John

  • 1Skin Tumour Unit, St John's Institute of Dermatology, King's College London, London, UK.

Immunology
|February 22, 2005
PubMed

Insights

Cytokine signaling activates signal transducers (STATs) regulating cell growth. Dysregulation of this JAK-STAT pathway is crucial in human tumors, particularly T-cell lymphomas.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Oncology

Background:

  • Cytokine-receptor interactions activate latent transcription factors, known as signal transducers and activators of transcription (STAT) proteins.
  • STAT proteins regulate critical cellular processes including growth, survival, and differentiation.
  • The JAK-STAT pathway is frequently dysregulated in human tumors, highlighting its role in maintaining cellular integrity.

Purpose of the Study:

  • To review current advancements in understanding STAT protein structure and function.
  • To elucidate the role of STAT signaling in the pathogenesis of T-cell lymphomas.

Main Methods:

  • Literature review of STAT structure and function.
  • Analysis of STAT signaling pathways in T-cell lymphoma development.

Main Results:

  • The review details the intricate mechanisms of STAT activation and function.
  • Evidence linking STAT signaling dysregulation to T-cell lymphoma pathogenesis is presented.

Conclusions:

  • STAT proteins are key regulators of cellular processes, and their aberrant signaling contributes to T-cell lymphomagenesis.
  • Further research into STAT pathways may offer therapeutic targets for T-cell lymphomas.

More Related Videos

The Use of Flow Cytometry to Assess the State of Chromatin in T Cells11:01

The Use of Flow Cytometry to Assess the State of Chromatin in T Cells

Published on: December 17, 2015

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...